| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003060521A3 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 01/22/2004 | WO2003055978A3 Gene recombination and hybrid protein development |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2003054140A3 Phosphate limited inducible promoter and a bacillus expression system |
| 01/22/2004 | WO2003052111A3 Cotton alpha-globulin promoter for seed-specific expression of transgenes |
| 01/22/2004 | WO2003052098A3 Method for controlled induction of somatic mutations and use thereof in proteomics |
| 01/22/2004 | WO2003048303A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003045316A3 Polynucleotide therapy |
| 01/22/2004 | WO2003037919A3 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 01/22/2004 | WO2003037257A3 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 01/22/2004 | WO2003037255A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 |
| 01/22/2004 | WO2003029453A3 Induction of gene expression by silencing of repressor genes |
| 01/22/2004 | WO2003029285A3 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 01/22/2004 | WO2003020962A3 Method of identifying glycosyl transferase binding compounds |
| 01/22/2004 | WO2003018838A3 Interaction detection on several probe arrays |
| 01/22/2004 | WO2003014386A3 Method for identifying macrocyclic polyketides |
| 01/22/2004 | WO2003014380A3 Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/22/2004 | WO2003013234A3 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |
| 01/22/2004 | WO2003008614A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced suca or sucb gene |
| 01/22/2004 | WO2003008612A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene |
| 01/22/2004 | WO2003008595A3 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/22/2004 | WO2003006497A3 Mutated photoproteins and their uses |
| 01/22/2004 | WO2003004701A3 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/22/2004 | WO2003001883A3 Gaba b1a receptor disruptions, compositions and methods relating thereto |
| 01/22/2004 | WO2002099120A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/22/2004 | WO2002098917A3 Human proteins and nucleic acids encoding same |
| 01/22/2004 | WO2002092814A3 Screening method for attenuating or virulence defective microbial cells |
| 01/22/2004 | WO2002088339A3 Bursal disease virus-like particles |
| 01/22/2004 | WO2002079452A3 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 01/22/2004 | WO2002076389A3 Compositions and methods to prevent metastasis from primary malignancies |
| 01/22/2004 | WO2002070729A3 Improved skin substitutes and uses thereof |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040016032 Development of novel highly chemoprotectant crucifer germplasm |
| 01/22/2004 | US20040016030 Methods and compositions for production of maize lines with increased transformability |
| 01/22/2004 | US20040016029 Growing a transgenic plant or plant seed transformed with a DNA molecule which encodes for a hypersensitive response elicitor protein or polypeptide |
| 01/22/2004 | US20040016028 Changing distribution of adenosine 5'-triphosphate and/or adenosine 5'-diphophate in plant cells |
| 01/22/2004 | US20040016027 Novel rice gene controlling tolerance to salt stress |
| 01/22/2004 | US20040016026 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 01/22/2004 | US20040016025 Rice promoters for regulation of plant expression |
| 01/22/2004 | US20040016024 Transcribing heterologous nucleic acid sequences in seeds |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016022 Methods of use of LEC1 polynucleotides and polypeptides |
| 01/22/2004 | US20040016021 Recombinant viral expression constructs of human alpha galactosidase nucleotide sequences |
| 01/22/2004 | US20040016020 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/22/2004 | US20040016019 Chimeric genes that express in cotton and encode insecticides and fungicides having substantially the insect toxicity and fungal toxicity of barley, nettle, and hevein lectins |
| 01/22/2004 | US20040016018 Plant retroelements and methods related thereto |
| 01/22/2004 | US20040016017 Nucleotide sequences for synthetic multimeric promoter element regions and plant promoters comprising the multimeric regions; methods for expressing a heterologous nucleotide sequence in a plant using the promoter sequences |
| 01/22/2004 | US20040016016 Compositions and methods for improving plant performance |
| 01/22/2004 | US20040016015 Providing recombinant nucleic acid of interest comprising heterologous nucleic acid and matrix attachment region, providing meristem tissue of plant of interest, introducing nucleic acid into meristem tissue, propagating plant |
| 01/22/2004 | US20040016014 High efficiency germline transformation system |
| 01/22/2004 | US20040016012 Transgenic animals for studying regulation of genes |
| 01/22/2004 | US20040016011 Mouse model for inducing hepatocellular carcinoma by targeted integration of hepatitis B virus genes |
| 01/22/2004 | US20040016009 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery, a method for such delivery, and a non-human mammal susceptible to such delivery |
| 01/22/2004 | US20040016008 Rodent whose genome comprises a mutant amyloid precursor protein transgene and an acetylcholinesterase transgene; use in identifying agents that affect the progression of Alzheimer's disease |
| 01/22/2004 | US20040016007 The chimeric mice can be immunized over a long time and enable one to obtain human antibodies against arbitrary antigens containing a human self-component |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040016005 Large-scale production of recombinant butyrylcholinesterase in cell culture, and in milk and/or urine of transgenic mammals; can be used to treat and/or prevent organophosphate pesticide poisoning, nerve gas poisoning, cocaine intoxication |
| 01/22/2004 | US20040014981 Cyanine dyes |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014946 Using mass spectroscopy to identify, reconstitute and determine the kinetics of multimeric polypeptide complexes; drug screening |
| 01/22/2004 | US20040014942 Transformation cells by introduction of a false-sense mutation at a target codon of a gene coding for a protein necessary for the growth of the cells, such protein synthesized from the gene thus mutated is non functional |
| 01/22/2004 | US20040014939 Comprises peptide with degratory activity for diagnosis, prevention and treatment of defects in vasodilation, hypotension and hypoglycemia |
| 01/22/2004 | US20040014779 Testing for immunology response moderators; viricides, antitumor agents |
| 01/22/2004 | US20040014709 Genetic engineered adenoviral vector coding interferon gene; therapy against bladder cancer |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014705 Supplying polypeptides; coupling with controller; therapy for autoimmune disease |
| 01/22/2004 | US20040014703 Aqueous solution containing cationic stabilizer |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014699 Antisense modulation of PTPRM expression |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014661 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 01/22/2004 | US20040014644 Prevent gene expression; genetic engineering |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014221 Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| 01/22/2004 | US20040014220 Using electroporation to transfer nucleotide sequences and biologicaly active molecules into peripheral human blood cells; gene therapy |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014217 Methods of transfection |
| 01/22/2004 | US20040014216 Using internal ribosome entry sites (IRES) to identifying and characterizing transcriptionally active regions in plants; tissue engineering; transgenic seeds |
| 01/22/2004 | US20040014215 Preparing cocurrent plant cultures and isolating cell cycle regulated genes or proteins |
| 01/22/2004 | US20040014207 Dendritic cell potentiation |
| 01/22/2004 | US20040014206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/22/2004 | US20040014197 Microbial strains and process for the manufacture of biomaterials |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014183 Secondary metabolite congener distribution modulation |
| 01/22/2004 | US20040014182 Nucleotide sequence encoding a benzaldehyde lyase, and process for stereoselectively synthesizing 2-hydroxyketones |
| 01/22/2004 | US20040014180 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014175 Producting proteases which differ from wild type in at least one amino acid for use in industrial and food applications such as textile treatment, detergents and protein degradation |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014172 Comprises retroviral polypeptide for generating genetic vaccine for preventing viral infections; viricides; gene expression inhibition |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014169 Novel G protein-coupled receptors |
| 01/22/2004 | US20040014167 Process for producing biopterin |
| 01/22/2004 | US20040014163 Immunoassay mixture for measuring calcium-dependent glutamate dehydrogenase activities and treating bone, teeth and oral diseases |